Ephedrine: direct, indirect or mixed acting sympathomimetic?

Paresh Solanki, Preeti P. Yadav, Naresh D. Kantharia

Abstract


Ephedrine is the principal alkaloid that is responsible for the physiological effects of herb ephedra. This herb is found in literature of India and China since ancient times because of its effectiveness as an anti-asthmatic. Ephedrine is classified as sympathomimetic drug. Despite extensive work in this field, the mechanism of action of ephedrine remains controversial. Initial studies classified ephedrine as indirectly acting sympathomimetic, subsequent studies showed ephedrine acts by mixed action by releasing noradrenaline and by acting directly on receptors. However, few recent studies on rat have shown predominant direct action on adrenergic receptors. Hence, there is marked controversy existing whether ephedrine is directly, indirectly or mixed acting drug.


Keywords


Ephedrine, Sympathomimetic

Full Text:

PDF

References


Gurley BJ, Wang P, Gardner SF. Ephedrine-type alkaloid content of nutritional supplements containing Ephedra sinica (Ma-huang) as determined by high performance liquid chromatography. J Pharm Sci. 1998;87(12):1547-53.

Young R, Gabryszuk M, Glennon RA. (−) Ephedrine and caffeine mutually potentiate one another’s amphetamine-like stimulus effects. Pharmacol Biochem Behav. 1998;61(2):169-73.

Anon. Begrüßung von Professor Dr. W. N. Nagai. Ber Dtsch Chem Ges. 1927;60:167-75.

E Merck. Bericht über das Jahr 1894. Darmstadt: E Merck; 1894.

Chen K, Schmidt CF. The action of ephedrine, the active principle of the Chinese drug Ma Huang. J Pharmacol Exp Ther. 1924;24(5):339-57.

Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol. 1948;153(3):586-600.

Miller T. Ephedrine, its use in the treatment of vascular hypotension and bronchial asthma. Ann Clin Med. 1926;4:713.

Miller TG, Chen K, Schmidt CF. Substitutes for ephedrine. J Am Med Assoc. 1926;87(1):50.

Chen K, editor. The effect of ephedrine on experimental shock and hemorrhage. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY: Royal Society of Medicine; 1924.

Stokes JH, McIntyre M. The use of ephedrine in controlling reactions to arsphenamine. Arch Dermatol. 1928;18(1):131.

Astrup A, Toubro S, Cannon S, Hein P, Madsen J. Thermogenic synergism between ephedrine and caffeine in healthy volunteers: a double-blind, placebo-controlled study. Metabolism. 1991;40(3):323-9.

McBride BF, Karapanos AK, Krudysz A, Kluger J, Coleman CI, White CM. Electrocardiographic and hemodynamic effects of a multicomponent dietary supplement containing ephedra and caffeine: a randomized controlled trial. JAMA. 2004;291(2):216-21.

Naik SD, Freudenberger RS. Ephedra-associated cardiomyopathy. Ann Pharmacother. 2004;38(3):400-3.

Persky AM, Berry NS, Pollack GM, Brouwer KL. Modelling the cardiovascular effects of ephedrine. Br J Clin Pharmacol. 2004;57(5):552-62.

Peters CM, O’Neill JO, Young JB, Bott-Silverman C. Is there an association between ephedra and heart failure? A case series. J Card Fail. 2005;11(1):9-11.

Haller CA, Jacob P, Benowitz NL. Short-term metabolic and hemodynamic effects of ephedra and guarana combinations. Clin Pharmacol Ther. 2005;77(6):560-71.

Vukovich MD, Schoorman R, Heilman C, Jacob P 3rd, Benowitz NL. Caffeine-herbal ephedra combination increases resting energy expenditure, heart rate and blood pressure. Clin Exp Pharmacol Physiol. 2005;32(1-2):47-53.

Westfall TC, Westfall DP. In: Bruton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s the Pharmacological Basis of Therapeutics. 12th Edition. New York: McGraw-Hill; 2011: 278-81.

Chen KK, Meek WJ. A comparative study of ephedrine, tyramine and amphetamine with special reference to the circulation. J Pharmacol Exper Therap. 1926;28:59-76.

Waldeck B, Widmark E. The interaction of ephedrine with beta-adrenoceptors in tracheal, cardiac and skeletal muscles. Clin Exp Pharmacol Physiol. 1985;12(4):439-42.

Vansal SS, Feller DR. Direct effects of ephedrine isomers on human beta-adrenergic receptor subtypes. Biochem Pharmacol. 1999;58(5):807-10.

McMahon LR, Cunningham KA. Discriminative stimulus effects of (−)-ephedrine in rats: analysis with catecholamine transporter and receptor ligands. Drug Alcohol Depend. 2003;70(3):255-64.

Burn JH, Rand MJ. The action of sympathomimetic amines in animals treated with reserpine. J Physiol. 1958;144(2):314-36.

Cairoli VJ, Reilly JF, Roberts J. Effect of reserpine pretreatment on the response of isolated papillary muscle to ephedrine. Br J Pharmacol Chemother. 1962;18(3):588-94.

Fleckenstein A, Burn JH. The effect of denervation on the action of sympathomimetic amines on the nictitating membrane. Br J Pharmacol Chemother. 1953;8(1):69-78.

Marley E. Action of some sympathomimetic amines on the cat’s iris, in situ or isolated. J Physiol. 1962;162(2):193-211.

Bao JX, Wang B, Yang ZC. Effects of ephedrine on postsynaptic alpha-adrenoceptors and presynaptic beta-adrenoceptors in isolated guinea pig portal veins. Zhongguo Yao Li Xue Bao. 1990;11(2):130-3.

Tye A, Baldesberger R, LaPidus JB, Patil PN. Steric aspects of adrenergic drugs. VI. Beta adrenergic effects of ephedrine isomers. J Pharmacol Exp Ther. 1967;157(2):356-62.

Kawasuji T, Koike K, Saito H. Chronotropic effects of optical isomers of ephedrine and methylephedrine in the isolated rat right atria and in vitro assessment of direct and indirect actions on beta 1-adrenoceptors. Biol Pharm Bull. 1996;19(11):1423-8.

Liles JT, Baber SR, Deng W, Porter JR, Corll C, Murthy SN, et al. Pressor responses to ephedrine are not impaired in dopamine beta-hydroxylase knockout mice. Br J Pharmacol. 2007;150(1):29-36.

Burn JH, Tainter ML. An analysis of the effect of cocaine on the actions of adrenaline and tyramine. J Physiol. 1931;71(2):169-93.

Burn J. The action of tyramine and ephedrine. J Pharmacol Exp Ther. 1932;46(1):75-95.

Burn JH. On vaso-dilator fibres in the sympathetic, and on the effect of circulating adrenaline in augmenting the vascular response to sympathetic stimulation. J Physiol. 1932;75(2):144-60.

Fleming WW, Trendelenburg U. The development of supersensitivity to norepinephrine after pretreatment with reserpine. J Pharmacol Exp Ther. 1961;133(1):41-51.

de Moraes S, de Carvalho FV. Reciprocal pressor effects between amphetamine and some sympathomimetic amines. Pharmacology. 1968;1(2):129-34.

Chidsey CA, Harrison DC, Braunwald E, editors. Release of norepinephrine from the heart by vasoactive amines. Proceedings of the Society for Experimental Biology and Medicine Society for Experimental Biology and Medicine. New York, NY: Royal Society of Medicine; 1962.

Andersen T, Gravenstein J, Hoff HE. Mephentermine and ephedrine in man: a comparative study on cardiovascular effects. Surv Anesthesiol. 1966;10(2):119-20.

Cohn JN. Comparative cardiovascular effects of tyramine, ephedrine, and norepinephrine in man. Circ Res. 1965;16(2):174-82.

Kobayashi S, Endou M, Sakuraya F, Matsuda N, Zhang XH, Azuma M, et al. The sympathomimetic actions of l-ephedrine and d-pseudoephedrine: direct receptor activation or norepinephrine release? Anesth Analg. 2003;97(5):1239-45.

Ma G, Bavadekar SA, Davis YM, Lalchandani SG, Nagmani R, Schaneberg BT, et al. Pharmacological effects of ephedrine alkaloids on human alpha(1)- and alpha(2)-adrenergic receptor subtypes. J Pharmacol Exp Ther. 2007;322(1):

-21.

Liles JT, Dabisch PA, Hude KE, Pradhan L, Varner KJ, Porter JR, et al. Pressor responses to ephedrine are mediated by a direct mechanism in the rat. J Pharmacol Exp Ther. 2006;316(1):95-105.